RadBone: bone toxicity following pelvic radiotherapy – a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-06-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/6/e056600.full |
| _version_ | 1811242558019338240 |
|---|---|
| author | Janelle Yorke Sarah O’Connell Sally Taylor Karen Johnson Robert G Bristow Martin Eden Kate Haslett John Moore Rohit Kochhar Victoria Chatzimavridou Grigoriadou Lisa H Barraclough Ivona Baricevic-Jones Zoe Merchant Thomas Westwood Anthony David Whetton Claire E Higham |
| author_facet | Janelle Yorke Sarah O’Connell Sally Taylor Karen Johnson Robert G Bristow Martin Eden Kate Haslett John Moore Rohit Kochhar Victoria Chatzimavridou Grigoriadou Lisa H Barraclough Ivona Baricevic-Jones Zoe Merchant Thomas Westwood Anthony David Whetton Claire E Higham |
| author_sort | Janelle Yorke |
| collection | DOAJ |
| first_indexed | 2024-04-12T13:54:05Z |
| format | Article |
| id | doaj.art-5840c0d9ec964b16b09e4e9d6aeb2c9c |
| institution | Directory Open Access Journal |
| issn | 2044-6055 |
| language | English |
| last_indexed | 2024-04-12T13:54:05Z |
| publishDate | 2022-06-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj.art-5840c0d9ec964b16b09e4e9d6aeb2c9c2022-12-22T03:30:26ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2021-056600RadBone: bone toxicity following pelvic radiotherapy – a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapyJanelle Yorke0Sarah O’Connell1Sally Taylor2Karen Johnson3Robert G Bristow4Martin Eden5Kate Haslett6John Moore7Rohit Kochhar8Victoria Chatzimavridou Grigoriadou9Lisa H Barraclough10Ivona Baricevic-Jones11Zoe Merchant12Thomas Westwood13Anthony David Whetton14Claire E Higham15Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UKInfectious Disease, University Hospital Limerick, Dooradoyle, IrelandChristie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UKPreventive Medicine, The University of Tennessee Health Science Center, Memphis, Tennessee, USADivision of Cancer Sciences, Faculty of Biology, Health and Medicine, University of Manchester; Cancer Research UK Manchester Institute and Manchester Cancer Research Centre; The Christie NHS Foundation Trust, Manchester, UKManchester Academic Health Sciences Centre, Health Innovation Manchester, Manchester, UK1Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK4Third Fleet, US Navy, San Diego, California, USADepartment of Radiology, The Christie NHS Foundation Trust, Manchester, UKDepartment of Endocrinology, The Christie Hospital NHS Foundation Trust, Manchester, UKDepartment of Clinical Oncology, The Christie Hospital NHS Foundation Trust, Manchester, UKStoller Biomarker Discovery Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UKGreater Manchester ‘Prehab4Cancer and Recovery programme’/Highly Specialist Occupational Therapist, GM Cancer alliance hosted by the Christie NHS Foundation Trust, Manchester, UKDepartment of Radiology, The Christie NHS Foundation Trust, Manchester, UKStoller Biomarker Discovery Centre, The University of Manchester, Manchester, UKDepartment of Endocrinology, The Christie Hospital NHS Foundation Trust, Manchester, UKhttps://bmjopen.bmj.com/content/12/6/e056600.full |
| spellingShingle | Janelle Yorke Sarah O’Connell Sally Taylor Karen Johnson Robert G Bristow Martin Eden Kate Haslett John Moore Rohit Kochhar Victoria Chatzimavridou Grigoriadou Lisa H Barraclough Ivona Baricevic-Jones Zoe Merchant Thomas Westwood Anthony David Whetton Claire E Higham RadBone: bone toxicity following pelvic radiotherapy – a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy BMJ Open |
| title | RadBone: bone toxicity following pelvic radiotherapy – a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy |
| title_full | RadBone: bone toxicity following pelvic radiotherapy – a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy |
| title_fullStr | RadBone: bone toxicity following pelvic radiotherapy – a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy |
| title_full_unstemmed | RadBone: bone toxicity following pelvic radiotherapy – a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy |
| title_short | RadBone: bone toxicity following pelvic radiotherapy – a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy |
| title_sort | radbone bone toxicity following pelvic radiotherapy a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy |
| url | https://bmjopen.bmj.com/content/12/6/e056600.full |
| work_keys_str_mv | AT janelleyorke radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT sarahoconnell radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT sallytaylor radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT karenjohnson radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT robertgbristow radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT martineden radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT katehaslett radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT johnmoore radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT rohitkochhar radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT victoriachatzimavridougrigoriadou radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT lisahbarraclough radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT ivonabaricevicjones radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT zoemerchant radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT thomaswestwood radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT anthonydavidwhetton radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy AT claireehigham radbonebonetoxicityfollowingpelvicradiotherapyaprospectiverandomisedcontrolledfeasibilitystudyevaluatingamusculoskeletalhealthpackageinwomenwithgynaecologicalcancersundergoingpelvicradiotherapy |